BruceMPrennerMD

Allergy & Immunology • San Diego, CA

Pediatric Asthma & Allergic Conditions

Founder of Allergy Associates Medical Group and Research Center

Join to view full profile

Dr. Prenner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Prenner's full profile

Already have an account?

Office
5555 Resevoir Drive Ste 210
San Diego Ca
San Diego, CA 92120
Phone+1 619-582-5564

Fax+1 619-582-5126

Education & Training

University of California (San Diego) Medical CenterFellowship, Allergy and Immunology, 1974 - 1976
University of California (San Diego) Medical CenterResidency, Pediatrics, 1973 - 1974
New York Presbyterian Hospital (Columbia Campus)Internship, Transitional Year, 1970 - 1971
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1970

Certifications & Licensure

CA State Medical License 1972 - 2025
American Board of Allergy and Immunology Allergy & Immunology
American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology

Clinical Trials

Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Start of enrollment: 2009 Oct 19
Completed
Phase 3

Publications & Presentations

PubMed

54 citations
A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary dise...
Bruce M. Prenner, Stan Bukofzer, Sarah Behm, Kathleen Feaheny, Bruce E. McNutt
Journal of Nuclear Cardiology. 2012-04-07
24 citations
Neonatal withdrawal syndrome associated with hydroxyzine hydrochloride.
Bruce M. Prenner
American Journal of Diseases of Children. 1977-05-01
214 citations
Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial
Eli O. Meltzer, Kerstin Malmstrom, Susan Lu, Bruce M. Prenner, Lynn Wei
The Journal of Allergy and Clinical Immunology. 2000-05-01

Press Mentions

Nasal Spray Improves Seasonal Allergic Rhinitis Symptoms in Children Aged 6 to 11 YearsAugust 17th, 2022

Professional Memberships

American Academy of Allergy Asthma and Immunology - AAAAI
Fellow

Industry Relationships

Consultant, Member Seakers Bureaus, Meda, Allergan, Teva, Mylan, Genentech